Man Group’s Starling Oncology Warrant STLNW Stock Holding History
Bought
Maintained
Sold
Other funds holding STLNW
OMC
LP
DM
WAM
DKCM
AGM
TCM
Man Group's STLNW Position: Q2 2026 in Review
Man Group held its Starling Oncology Warrant (STLNW) position steady in Q2 2026 at 88,824 shares worth $2.75K. The position accounts for ﹤0.01% of the portfolio, ranked #2316.
Man Group first reported a position in STLNW in Q3 2020 and has held it in 21 quarters since. The position peaked at $185K in Q4 2020. 12 funds tracked by Wall St. Rank hold STLNW as of Q2 2026.
- Man Group held 88,824 shares of Starling Oncology Warrant worth $2.75K as of Q2 2026.
- Man Group left its Starling Oncology Warrant share count unchanged in Q2 2026.
- Starling Oncology Warrant made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #2316 holding.
- Man Group first reported a position in Starling Oncology Warrant in Q3 2020 and has held it in 21 quarters since.
- Man Group's Starling Oncology Warrant position peaked at $185K in Q4 2020.
- 12 funds tracked by Wall St. Rank held Starling Oncology Warrant as of Q2 2026.
Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.